Abiopharma

New Form S-3/A - Gryphon Digital Mining, Inc. Filed: 2025-08-29 AccNo: 0001213900-25-082524 Size: 271 KB

New Form 144 - JOHNSON & JOHNSON Filed: 2025-08-29 AccNo: 0001959173-25-005640 Size: 4 KB

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

New Form 144 - OptimizeRx Corp Filed: 2025-08-29 AccNo: 0002007317-25-001000 Size: 6 KB

New Form 424B5 - Safety Shot, Inc. Filed: 2025-08-29 AccNo: 0001641172-25-025941 Size: 452 KB

New Form 144 - COLLEGIUM PHARMACEUTICAL, INC Filed: 2025-08-29 AccNo: 0002007317-25-000999 Size: 4 KB

IDEAYA Biosciences to Present First Median Overall Survival Data from Phase 2 Trial of the Darovasertib / Crizotinib Combination in Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress

Director Pershing Edward 🟡 adjusted position in 254.9K shares (2 derivative) of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) at $2.86 Transaction Date: Aug 29, 2025 | Filing ID: 025921

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Semler Scientific, Inc. Investors – SMLR

New Form 8-K - CEL SCI CORP Filed: 2025-08-29 AccNo: 0001654954-25-010184 Size: 541 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 144 - IONIS PHARMACEUTICALS INC Filed: 2025-08-29 AccNo: 0000048532-25-000002 Size: 4 KB

Tenet - Tenet to Participate in the 2025 Wells Fargo Healthcare Conference